Anavex Life Sciences Corp
Fundamentals
Oldest to newest| Line | Sep 2021 | Sep 2022 | Sep 2023 | Sep 2024 | Sep 2025 |
|---|---|---|---|---|---|
| Operating income | −$42.0M | −$51.0M | −$55.8M | −$52.9M | −$51.4M |
| Net income | −$37.9M | −$48.0M | −$47.5M | −$43.0M | −$46.4M |
| Operating cash flow | −$30.4M | −$24.2M | −$27.8M | −$30.8M | −$39.0M |
| Cash | $152.1M | $149.2M | $151.0M | $132.2M | $102.6M |
| Shares outstanding | 75.9M | 77.9M | 82.1M | 84.8M | 86.7M |